The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Amgen (Inst); AstraZeneca; Novartis; Pfizer/Edimark; Sandoz
Research Funding - Resilience Care (Inst)
Other Relationship - Pfizer/Edimark (Inst)
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).
 
Davide Soldato
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Novartis
 
Eva Blondeaux
Research Funding - Gilead Sciences
 
Marco Bruzzone
No Relationships to Disclose
 
Silvia Mura
No Relationships to Disclose
 
Michelino De Laurentiis
Honoraria - Amgen; AstraZeneca; Gilead Sciences; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Genzyme; Gilead Sciences; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Takeda
Speakers' Bureau - Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genzyme (Inst); Lilly; Macrogenics (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
 
Anna Turletti
Travel, Accommodations, Expenses - Roche
 
Sabino De Placido
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Giancarlo Bisagni
No Relationships to Disclose
 
Anita Rimanti
No Relationships to Disclose
 
Andrea Michelotti
Consulting or Advisory Role - AstraZeneca; Celgene; EISAI; Istituto Gentili; Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Celgene; Eisai; Ipsen; Novartis
 
Alessandra Fabi
Consulting or Advisory Role - AstraZeneca; Dompé Farmaceutici; Eisai; Epionpharma; Exact Sciences; Gilead Sciences; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagan; sophos
 
Antonio Russo
Honoraria - Roche
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Pfizer
Speakers' Bureau - Roche
 
Stefania Gori
No Relationships to Disclose
 
Antonio Durando
No Relationships to Disclose
 
Guilherme Nader Marta
Research Funding - AstraZeneca (Inst); Novartis (Inst)
 
Evandro de Azambuja
Honoraria - Libbs (Inst); Novartis/Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech; SeaGen; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca (Inst); Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech
 
Antonio Di Meglio
Expert Testimony - Kephren; techspert.io
 
Ines Vaz-Luis
No Relationships to Disclose
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo; Daiichi Sankyo; Ipsen; Knight Therapeutics; Libbs; Lilly; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Lucia Del Mastro
Honoraria - Lilly; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Pfizer; Roche